AGWRX | FAFGX | AGWRX / FAFGX | |
Total Expense Ratio | 1.39 | 0.40 | 347% |
Annual Report Gross Expense Ratio | 1.47 | 0.40 | 368% |
Fund Existence | 22 years | 4 years | - |
Gain YTD | -11.748 | -7.509 | 156% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.5B | 272B | 5% |
Annual Yield % from dividends | 0.00 | 0.62 | - |
Returns for 1 year | -5.63 | -1.81 | 311% |
Returns for 3 years | 10.57 | 10.34 | 102% |
Returns for 5 years | 48.33 | N/A | - |
Returns for 10 years | 56.66 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TMDV | 44.30 | 0.83 | +1.91% |
ProShares Russell US Dividend Grwr ETF | |||
FLIN | 36.10 | -0.34 | -0.93% |
Franklin FTSE India ETF | |||
IBHI | 22.41 | -0.30 | -1.32% |
iShares iBonds 2029 Term HY & Inc ETF | |||
ETB | 12.86 | -0.36 | -2.72% |
Eaton Vance Tax-Managed Buy-Write Income Fund | |||
FMED | 22.15 | -0.70 | -3.06% |
Fidelity Disruptive Medicine ETF |